Hello, all!
It’s been a few months since I’ve last posted (had a baby in October and my dad’s PCa was stable-ish) but it looks like the most recent scans showed growth. He’s 71, dx’ed nearly 3 years ago, and has already utilized Zoladex, docetaxel, and Zytiga and some targeted radiation. He’s had widespread mets since dx but largely feels pretty well (aside from Covid knocking him on his rear in October).
With Zytiga losing efficacy, we have choices ahead of us: Xofigo, Jevtana, or three different clinical trials. I feel knowledgeable about the risks and benefits of Xofigo and Jevtana but I’ve never seen these trials. Would love some input on them if you’ve got some expertise to lend!!
Option 1: sEphB4-HSA clinicaltrials.gov/ct2/show...
Option 2: Galunisertib (LY2157299) clinicaltrials.gov/ct2/show...
Option 3: ARV-110
clinicaltrials.gov/ct2/show...
Just upon preliminary research, if we go the trial route, I’m thinking ARV-110 might be the way to go.
Thank you sincerely in advance!
Annette